Sign up to save your podcasts
Or
Share GLP-1 Wars: Obesity Week Highlights, Novo Nordisk vs. Pfizer, and Addiction Breakthroughs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GLP-1 Wars: Obesity Week Highlights, Novo Nordisk vs. Pfizer, and Addiction Breakthroughs
Resources for the Community:
___________________________________________________________________
https://linktr.ee/theplussidezpodcast
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Find Your US Representatives
https://www.usa.gov/elected-officials
______________________________________________________________________
Get the latest buzz on GLP-1 therapies and the future of metabolic medicine! This episode provides an in-depth look at what's coming out of Obesity Week in Atlanta, GA, featuring expert insights from Dave Knapp from On the Pen.
Key Topics & Breakthroughs:
Corporate Battle for Biotech: We break down the surprise counteroffer by Novo Nordisk to acquire Metsera, the obesity biotech company that Pfizer had recently announced it was buying, setting the stage for a major pharmaceutical turf war.
Pipeline Watch: Dive into the plethora of new therapies in current clinical trials, including the latest developments from Viking Therapeutics and the push for Oral GLP-1s.
GLP-1's New Frontier: Discover the groundbreaking research on GLP-1's potential role in treating alcohol and narcotics addictions. We also discuss Brenipatide and its surprising dual focus on alcohol abuse and asthma.
Tune in for a comprehensive review of the medications, mergers, and clinical trials shaping the next generation of weight loss and metabolic treatments.
______________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
/ @theplussidez
______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
View all episodes
By Kim Carlos
4.5
205205 ratings
Resources for the Community:
___________________________________________________________________
https://linktr.ee/theplussidezpodcast
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Find Your US Representatives
https://www.usa.gov/elected-officials
______________________________________________________________________
Get the latest buzz on GLP-1 therapies and the future of metabolic medicine! This episode provides an in-depth look at what's coming out of Obesity Week in Atlanta, GA, featuring expert insights from Dave Knapp from On the Pen.
Key Topics & Breakthroughs:
Corporate Battle for Biotech: We break down the surprise counteroffer by Novo Nordisk to acquire Metsera, the obesity biotech company that Pfizer had recently announced it was buying, setting the stage for a major pharmaceutical turf war.
Pipeline Watch: Dive into the plethora of new therapies in current clinical trials, including the latest developments from Viking Therapeutics and the push for Oral GLP-1s.
GLP-1's New Frontier: Discover the groundbreaking research on GLP-1's potential role in treating alcohol and narcotics addictions. We also discuss Brenipatide and its surprising dual focus on alcohol abuse and asthma.
Tune in for a comprehensive review of the medications, mergers, and clinical trials shaping the next generation of weight loss and metabolic treatments.
______________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
/ @theplussidez
______________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories
Send us Fan Mail!
Support the show
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
More shows like The Plus SideZ: A Guide to GLP-1 & Metabolic Health
View all
Half Size Me
2,199 Listeners
The Hormone Solution with Karen Martel
336 Listeners
Everyday Wellness: Midlife Hormones, Menopause, and Science for Women 35+
144 Listeners
BETTER! Muscle, Mobility, Metabolism & (Peri)Menopause with Dr. Stephanie
617 Listeners
The Holistic GLP-1 Podcast with Elizabeth McGann
48 Listeners
The Dr. Tyna Show
1,638 Listeners
Docs Who Lift
391 Listeners
The Obesity Guide with Matthea Rentea MD
244 Listeners
On The Pen With Dave Knapp
363 Listeners
Game-Changing Health
36 Listeners
The Peptide Podcast
87 Listeners
Fat Science
168 Listeners
The Tamsen Show
406 Listeners
GLP-1 Hub: Support, Community, and Weight Loss
81 Listeners
GLP-1 Tribe
44 Listeners